Skip to content

Cost of treatment and care becoming sensitive issue for UK as NHS faces spending slow-down

Risk of disease progression linked to CD4 cell count and HIV DNA level during primary infection

BHIVA: One in five diagnosed HIV-positive with low CD4 counts not on treatment in 2004

BHIVA: UK HIV patients remained on first combination for almost seven years during early-HAART era

HAART failure rate halves in seven years

Graves' disease may be a risk for patients starting ART with a low CD4 cell count who then have good immune restoratation

Treatment started early in HIV infection effective and well tolerated for up to five years

Best results in HIV-positive children if treatment started before five months of age

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS